Further increasing the utility of this model, human tau was also highly expressed in other areas of the brain including thalamic and midbrain regions (Fig. 1s–x), enabling the use of the AAV1-TauP301L model to evaluate genetic modifiers of non-cortical tauopathies. Here, MAPT is linked to tauopathy.